Bicycle Therapeutics plcBCYCNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank90
5Y CAGR+9.0%
Year-over-Year Change
Year-over-year net income growth rate
5Y CAGR
+9.0%/yr
Long-term compound
Percentile
P90
Near historical high
vs 5Y Ago
1.5x
Solid growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 25.14% |
| Q2 2025 | -29.95% |
| Q1 2025 | -17.16% |
| Q4 2024 | -2.07% |
| Q3 2024 | -27.60% |
| Q2 2024 | -49.88% |
| Q1 2024 | 45.90% |
| Q4 2023 | 1.60% |
| Q3 2023 | -17.12% |
| Q2 2023 | -9.06% |
| Q1 2023 | -30.31% |
| Q4 2022 | -5.75% |
| Q3 2022 | -5.66% |
| Q2 2022 | 2.67% |
| Q1 2022 | -52.82% |
| Q4 2021 | -22.88% |
| Q3 2021 | 18.06% |
| Q2 2021 | -10.64% |
| Q1 2021 | 7.12% |
| Q4 2020 | -71.96% |
| Q3 2020 | 16.32% |
| Q2 2020 | -6.99% |
| Q1 2020 | -157.01% |
| Q4 2019 | 53.53% |
| Q3 2019 | 7.19% |
| Q2 2019 | -57.11% |
| Q1 2019 | 2.08% |
| Q4 2018 | 13.66% |
| Q3 2018 | -54.49% |
| Q2 2018 | -96.49% |
| Q1 2018 | 56.50% |
| Q4 2017 | 0.00% |